UC Riverside researchers develop new drugs that target therapeutically relevant protein surfaces

UC Riverside biomedical scientist’s decades-long work moves to clinical trials

Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are...

Scientists unlock new molecular secrets to unravel the mystery

The device aims to reduce brain swelling and deliver a neuroprotective drug

Novel agents 135H11 and 135H12 move research closer to drug development

Whether we like it or not, everyone accumulates fat. For women, it usually accumulates around the hips, resulting in a pear-shaped look. In men, fat tends to build up around the abdomen, creating an apple shape. As it turns out, it’s healthier to be a pear than an apple. A...

UC Riverside researchers show that in parasitic worm infection both the host and the worm produce cannabis-like molecules

UC Riverside Bridges to the Baccalaureate Program receives 2018 Inspiring Programs in STEM Award from INSIGHT Into Diversity magazine

UC Riverside’s Maurizio Pellecchia receives grants totaling nearly $2.5 million from National Academy of Sciences, Engineering, and Medicine; and National Institute of Neurological Disorders and Stroke

UC Riverside biomedical scientists offer simple advice: keep the brain active

UC Riverside-led study shows that ‘good inflammation’ promotes axon myelination